Cardiac and vascular safety liabilities using totality of evidence approach

3d,Rendering,Blood,Cells,With,Plaque,Buildup,Of,Cholesterol,Symbol

US-FDA recommend integration of both preclinical (S7B) and clinical (E14) data to improve risk assessment, reduce reliance on TQT clinical studies, streamlined drug-development, simplified decision-making processes, effective risk-communication.